Clinical trialNCT03788746CompletedObservational

Prevalence of PD-L1 Expression in Patients With Advanced Urothelial Carcinoma

SponsorAstraZenecaEnrollment181Urothelial Carcinoma

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Joshua Meeks
Northwestern University
Study Chair
clinicaltrials.gov ↗
Petros Grivas, MD
University of Washington
Study ChairKOL profile →
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

58 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Research Site
Little Rock, Arkansas, United States
Research Site
Glendale, California, United States
Research Site
Los Angeles, California, United States
Research Site
Los Angeles, California, United States
Research Site
Monterey, California, United States
Research Site
Santa Rosa, California, United States
Research Site
Denver, Colorado, United States
Research Site
Englewood, Colorado, United States
Research Site
Hartford, Connecticut, United States
Research Site
Stamford, Connecticut, United States
Research Site
Boca Raton, Florida, United States
Research Site
Hialeah, Florida, United States
Research Site
Jacksonville, Florida, United States
Research Site
Augusta, Georgia, United States
Research Site
Roswell, Georgia, United States
Research Site
Geneva, Illinois, United States
Research Site
Harvey, Illinois, United States
Research Site
Lake Barrington, Illinois, United States
Research Site
Naperville, Illinois, United States
Research Site
Greenwood, Indiana, United States
Research Site
Lafayette, Indiana, United States
Research Site
Muncie, Indiana, United States
Research Site
Cedar Rapids, Iowa, United States
Research Site
Waterloo, Iowa, United States
Research Site
Kansas City, Kansas, United States
Research Site
Wichita, Kansas, United States
Research Site
Baton Rouge, Louisiana, United States
Research Site
Shreveport, Louisiana, United States
Research Site
Brewer, Maine, United States
Research Site
Lewiston, Maine, United States
Research Site
Grand Rapids, Michigan, United States
Research Site
Duluth, Minnesota, United States
Research Site
Saint Cloud, Minnesota, United States
Research Site
Bridgeton, Missouri, United States
Research Site
Las Vegas, Nevada, United States
Research Site
Berkeley Heights, New Jersey, United States
Research Site
East Brunswick, New Jersey, United States
Research Site
Englewood, New Jersey, United States
Research Site
Freehold, New Jersey, United States
Research Site
Little Silver, New Jersey, United States

18 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 17 Jan 2019
Primary completion: 12 Jan 2022
Completion: 25 May 2023
Last update posted: 22 Feb 2024
Registered enrollment: 181
Registry id: NCT03788746

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.